3 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 3 |
| Phase 2 | 1 | Terminated 1 |
Follow Ulcer: new trials by email Literature Review of Ulcer trials Research Report on Ulcer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The ASCEND Study: A Study to Investigate the Safety and Clinical Effect of Nexagon to Treat Slow Healing Diabetic Foot Ulcers Nexagon®, Nexagon® vehicle - Diabetic Foot Ulcer | Phase 1 / Phase 2 | Terminated | OcuNexus Therapeutics, Inc. | 24 | 2009-04-01 | 2010-08-31 |
| Study to Evaluate Bone Marrow Cells in the Treatment of Chronic Wounds Bone Marrow Aspirate, Cultured Bone Marrow Cells, Control - Ulcer | Phase 1 | Terminated | Dr. E.Badiavas | 11 | 2008-07-01 | 2018-04-30 |
| Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis rhIL-11 - Ulcerative Colitis, Inflammatory Bowel Disease | Phase 1 | Terminated | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-05-18 |
Colitis (1) · Colitis, Ulcerative (1) · Diabetic Foot (1) · Inflammatory Bowel Diseases (1)
Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Cardiovascular Diseases (1) · Colonic Diseases (1) · Diabetes Complications (1) · Diabetes Mellitus (1) · Diabetic Angiopathies (1) · Diabetic Neuropathies (1) · Digestive System Diseases (1) · Endocrine System Diseases (1) · Foot Ulcer (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1) · Leg Ulcer (1)
Standard of Care (1) · oprelvekin (1)
Dr. E.Badiavas (1) · OcuNexus Therapeutics, Inc. (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
New Zealand (1)
Evangelos V Badiavas, MD, PhD (1)
R01AG027874 (1)